REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Fresenius Kabi Malaysia Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Fresenius Kabi Malaysia Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Trading of products in relation to infusions therapy, parenteral nutrition, enteral nutrition and ambulatory care and oncology and compounding service operations.

Headquarters
3-1 & 3-2, Axis Technology Centre, Lot 13, Jalan 51A/225
Petaling Jaya; Selangor; Postal Code: 46100

Contact Details: Purchase the Fresenius Kabi Malaysia Sdn. Bhd. report to view the information.

Website: http://www.fresenius-kabi.com

Basic Information
Outstanding Shares:
Purchase the Fresenius Kabi Malaysia Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Fresenius Kabi Malaysia Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Fresenius Kabi Malaysia Sdn. Bhd. report to view the information.
Incorporation Date:
December 21, 2000
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Fresenius Kabi Malaysia Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
0.33%▲
Total operating revenue
0.33%▲
Operating profit (EBIT)
8.81%▲
EBITDA
8.57%▲
Net Profit (Loss) for the Period
4.03%▲
Total assets
-1.17%▼
Total equity
-11.52%▼
Operating Profit Margin (ROS)
0.65%▲
Net Profit Margin
0.21%▲
Return on Equity (ROE)
3.07%▲
Debt to Equity Ratio
-0.3%▼
Quick Ratio
-0.12%▼
Cash Ratio
0.01%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo